Psychopharmacology Issues Research Articles in May 2022 Edition
May 17, 2022
May 17, 2022
BASEL, Switzerland, May 17 -- Psychopharmacology, a peer-reviewed journal from the European Behavioural Pharmacology Society that says it covers elucidating mechanisms by which drugs affect behavior, published research articles, including the following topics, in its May 2022 Special Issue on Cannabis and Cannabinoids:
Reviews:
* Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
* Is resting-state functional connectivity altered in reg . . .
Reviews:
* Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
* Is resting-state functional connectivity altered in reg . . .
